Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate.


Autoria(s): McMullin, Mary; Nugent, E.; Thompson, Alexander; Hull, D.; Jones, F.G.; Grimwade, D.
Data(s)

01/09/2005

Identificador

http://pure.qub.ac.uk/portal/en/publications/prolonged-molecular-remission-in-pmlraralphapositive-acute-promyelocytic-leukemia-treated-with-minimal-chemotherapy-followed-by-maintenance-including-the-histone-deacetylase-inhibitor-sodium-valproate(8a0e8505-c053-4627-afd8-1b2fa7cfa83e).html

http://dx.doi.org/10.1038/sj.leu.2403883

http://www.scopus.com/inward/record.url?scp=26944443973&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

McMullin , M , Nugent , E , Thompson , A , Hull , D , Jones , F G & Grimwade , D 2005 , ' Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate. ' Leukemia , vol 19(9) , no. 9 , pp. 1676-1677 . DOI: 10.1038/sj.leu.2403883

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2720 #Hematology #/dk/atira/pure/subjectarea/asjc/1300/1306 #Cancer Research
Tipo

article